ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
Gabriel Gregoratos,Melvin D. Cheitlin,A. Conill,Andrew E. Epstein,Christopher L. Fellows,T. B. Ferguson,Roger A. Freedman,Mark A. Hlatky,Gerald V. Naccarelli,Sanjeev Saksena,Robert C. Schlant,Michael J. Silka +11 more
Reads0
Chats0
TLDR
These guidelines include expanded sections on selection of pacemakers and ICDs, optimization of technology, cost, and follow-up of implanted devices, and recommendations that are evidence based whenever possible.Abstract:
The publication of major studies dealing with the natural history of bradyarrhythmias and tachyarrhythmias and major advances in the technology of pacemakers and implantable cardioverter-defibrillators (ICDs) has mandated this revision of the 1991 ACC/AHA Guidelines for Implantation of Pacemakers and Antiarrhythmia Devices.
This executive summary appears in the April 7, 1998 issue of Circulation. The full text of the guidelines, including the ACC/AHA Class I, II, and III recommendations, is published in the April 1998 issue of the Journal of the American College of Cardiology. Reprints of both the executive summary and the full text are available from both organizations.
Following extensive review of the medical literature and related documents previously published by the American College of Cardiology, the American Heart Association, and the North American Society for Pacing and Electrophysiology, the writing committee developed recommendations that are evidence based whenever possible.
Evidence supporting current recommendations is ranked as level A if the data were derived from multiple randomized clinical trials involving a large number of individuals. Evidence was ranked as level B when data were derived from a limited number of trials involving comparatively small numbers of patients or from well-designed data analysis of nonrandomized studies or observational data registries. Evidence was ranked as level C when consensus of expert opinion was the primary source of recommendation. The committee emphasizes that for certain conditions for which no other therapies are available, the indications for device therapies are based on years of clinical experience as well as expert consensus and are thus well supported, even though the evidence was ranked as level C.
These guidelines include expanded sections on selection of pacemakers and ICDs, optimization of technology, cost, and follow-up of implanted devices. The follow-up sections are relatively brief because in many instances the type and frequency of follow-up examinations …read more
Citations
More filters
Journal ArticleDOI
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
Serge Cazeau,Christophe Leclercq,Thomas Lavergne,S Walker,Varma C,Cecilia Linde,Stéphane Garrigue,Lukas Kappenberger,G A Haywood,Massimo Santini,Bailleul C,Jean-Claude Daubert,Multisite Stimulation in Cardiomyopathies (Mustic) Study Investigators +12 more
TL;DR: In this article, transvenous atriobiventricular pacemakers (with leads in one atrium and each ventricle) were used to reduce ventricular asynchrony.
Journal ArticleDOI
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
James B. Young,William T. Abraham,Andrew L. Smith,Angel R. Leon,Randy Lieberman,Bruce L. Wilkoff,Robert C. Canby,John S. Schroeder,L. Bing Liem,Shelley A. Hall,Kevin R. Wheelan +10 more
TL;DR: Cardiac resynchronization improved quality of life, functional status, and exercise capacity in patients with moderate to severe HF, a wide QRS interval, and life-threatening arrhythmias without proarrhythmia or compromised ICD function.
Journal ArticleDOI
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
Gabriel Gregoratos,Jonathan Abrams,Andrew E. Epstein,Roger A. Freedman,David L. Hayes,Mark A. Hlatky,Richard E. Kerber,Gerald V. Naccarelli,Mark H. Schoenfeld,Michael J. Silka,Stephen L. Winters,Raymond J. Gibbons,Elliott M. Antman,Joseph S. Alpert,Loren F. Hiratzka,David P. Faxon,Alice K. Jacobs,Valentin Fuster,Sidney C. Smith +18 more
TL;DR: The current update of the ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices includes several significant changes in the recommendations and in the supporting narrative portion.
Journal ArticleDOI
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Barry J. Maron,Win Kuang Shen,Mark S. Link,Andrew E. Epstein,Adrian K. Almquist,James P. Daubert,Gust H. Bardy,Stefano Favale,Robert F. Rea,Giuseppe Boriani,N.A. Mark Estes,Paolo Spirito,Susan A. Casey,Marshall S. Stanton,Sandro Betocchi +14 more
TL;DR: In this article, the authors conducted a retrospective multicenter study of the efficacy of implantable cardioverter-defibrillators in preventing sudden death in 128 patients with hypertrophic cardiomyopathy who were judged to be at high risk for sudden death.
Journal ArticleDOI
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction
Gervasio A. Lamas,Kerry L. Lee,Michael O. Sweeney,Russell Silverman,Angel R. Leon,Raymond Yee,Roger A. Marinchak,Greg C. Flaker,Eleanor Schron,E. John Orav,Anne S. Hellkamp,Stephen Greer,John H. McAnulty,Kenneth A. Ellenbogen,Frederick A. Ehlert,Roger A. Freedman,N.A. Mark Estes,Arnold J. Greenspon,Lee Goldman +18 more
TL;DR: Overall, dual-chamber pacing offers significant improvement as compared with ventricular pacing, and reduces the risk of atrial fibrillation, reduces signs and symptoms of heart failure, and slightly improves the quality of life.
Related Papers (5)
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
Gabriel Gregoratos,Jonathan Abrams,Andrew E. Epstein,Roger A. Freedman,David L. Hayes,Mark A. Hlatky,Richard E. Kerber,Gerald V. Naccarelli,Mark H. Schoenfeld,Michael J. Silka,Stephen L. Winters,Raymond J. Gibbons,Elliott M. Antman,Joseph S. Alpert,Loren F. Hiratzka,David P. Faxon,Alice K. Jacobs,Valentin Fuster,Sidney C. Smith +18 more